Articles published by NovaBay Pharmaceuticals, Inc.
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
NBY
![](https://mms.businesswire.com/media/20240801558807/en/2203442/22/NBY_logo.jpg)
NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
August 01, 2024
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240725797972/en/2197570/22/NBY_logo.jpg)
NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering
July 26, 2024
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240711674681/en/2183242/22/NBY_logo.jpg)
NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million
July 11, 2024
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240419003631/en/2104001/22/NBY_logo.jpg)
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales
January 30, 2024
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results
November 09, 2023
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023
November 02, 2023
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs
October 11, 2023
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft
September 14, 2023
Via Business Wire
Tickers
NBY
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.